Institutional investors purchased a net $2.6 million shares of NEO during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 35.84% of the shares outstanding that institutional investors hold is among the lowest in the Medical/Nursing Services industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 2.0 Million shares of Neogenomics Inc